SCHEMBL11021677

SCHEMBL11021677

CCOc1ccc(-c2ccccc2O)cc1OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.50
▸ AR P10275 1/20 0.50
▸ MAPT P10636 5/20 0.48
▸ TP53 P04637 1/20 0.48
▸ RXFP1 Q9HBX9 1/20 0.48
▸ PTPRC P08575 1/20 0.48
▸ S1PR1 P21453 5/20 0.47
▸ S1PR3 Q99500 2/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ ALOX5 P09917 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ KMT2A Q03164 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ GABRA1 P14867 2/20 0.46
▸ GABRB2 P47870 2/20 0.46
▸ ESR2 Q92731 1/20 0.45
▸ GLA P06280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1778039 0.78 HSD17B10 (0.65) MAPTS1PR1S1PR3KDM4ENPC1
SCHEMBL11021395 0.77 NQO1 (0.52) MAPTTP53KDM4ENPC1HSD17B10
SCHEMBL6013688 0.77 MKNK1 (0.51) MAPTTP53RXFP1PTPRCRAB9A
SCHEMBL3883588 0.77 MEN1 (0.51) MAPTTP53RXFP1PTPRCKDM4E
SCHEMBL27814160 0.77 KDM4E (0.60) MAPTTP53RXFP1S1PR1KDM4E
SCHEMBL11017769 0.77 RXRA (0.51) MAPTTP53KDM4EHSD17B10KMT2A
SCHEMBL28554230 0.75 PDK2 (0.47) MAPTTP53KDM4ENPC1HSD17B10
SCHEMBL22381396 0.74 PGR (0.67) PGRARMAPTTP53KDM4E
SCHEMBL22381391 0.74 PGR (0.62) PGRARMAPTTP53KDM4E
SCHEMBL4744927 0.72 MEN1 (0.48) MAPTTP53PTPRCKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0157652-A1 2-, 3- And 4-biphenyloxyaminoalkanes and related compounds, their preparation and uses, and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1985-10-09 — — EP disclosed
Send feedback